Inhibition of tetramethylpyrazine on P-gp, MRP2, MRP3 and MRP5 in multidrug resistant human hepatocellular carcinoma cells

  • Authors:
    • Xuan-Bin Wang
    • Shan-Shan Wang
    • Qiu-Fang Zhang
    • Ming Liu
    • Hong-Liang Li
    • Ying Liu
    • Jia-Ning Wang
    • Fei Zheng
    • Ling-Yun Guo
    • Ji-Zhou Xiang
  • View Affiliations

  • Published online on: January 1, 2010     https://doi.org/10.3892/or_00000625
  • Pages: 211-215
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Some membrane transporters in liver, such as P-glycoprotein, multidrug resistance-associated protein 2 (MRP2), MRP3, and MRP5 can lead to a complex multidrug resistance (MDR) to antineoplastic agents. How to inhibit these proteins is still an issue. Tetramethylpyrazine is a bioactive constituent isolated from the root of Ligusticum chuanxiong Hort, a Chinese herb. Recent studies showed that it can enhance the chemosensitivity effects of a drug on human hepatocellular carcinoma cells, acting as a multidrug resistance modulator. In this study, the reversal effect of TMP on MDR was evaluated and its activity mechanism in vitro was explored. The IC50 value shows that TMP reversed the multidrug resistance of BEL-7402/ADM cells 9.23-fold (P<0.01) at the concentration of 600 µM. The mean fluorescence intensity of ADM in BEL-7402/ADM cells with TMP was found to be 163.78±39.5% (P<0.01) versus in BEL-7402/ADM cells without TMP by flow cytometry and 126.73±28.72% in BEL-7402/ADM cells with TMP versus in BEL-7402/ADM cells without TMP (P<0.01) by high performance liquid chromatography, respectively. It was also found that the mRNA level of multidrug resistant gene MDR1, MRP2, MRP3 and MRP5 and the level of the proteins they encode were decreased after treatment with TMP, indicating that TMP can effectively reverse the MDR in BEL-7402/ADM cells, and its activity mechanism may be correlated with the down-regulation of expression in these transporters.

Related Articles

Journal Cover

January 2010
Volume 23 Issue 1

Print ISSN: 1021-335X
Online ISSN:1791-2431

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Wang X, Wang S, Zhang Q, Liu M, Li H, Liu Y, Wang J, Zheng F, Guo L, Xiang J, Xiang J, et al: Inhibition of tetramethylpyrazine on P-gp, MRP2, MRP3 and MRP5 in multidrug resistant human hepatocellular carcinoma cells. Oncol Rep 23: 211-215, 2010.
APA
Wang, X., Wang, S., Zhang, Q., Liu, M., Li, H., Liu, Y. ... Xiang, J. (2010). Inhibition of tetramethylpyrazine on P-gp, MRP2, MRP3 and MRP5 in multidrug resistant human hepatocellular carcinoma cells. Oncology Reports, 23, 211-215. https://doi.org/10.3892/or_00000625
MLA
Wang, X., Wang, S., Zhang, Q., Liu, M., Li, H., Liu, Y., Wang, J., Zheng, F., Guo, L., Xiang, J."Inhibition of tetramethylpyrazine on P-gp, MRP2, MRP3 and MRP5 in multidrug resistant human hepatocellular carcinoma cells". Oncology Reports 23.1 (2010): 211-215.
Chicago
Wang, X., Wang, S., Zhang, Q., Liu, M., Li, H., Liu, Y., Wang, J., Zheng, F., Guo, L., Xiang, J."Inhibition of tetramethylpyrazine on P-gp, MRP2, MRP3 and MRP5 in multidrug resistant human hepatocellular carcinoma cells". Oncology Reports 23, no. 1 (2010): 211-215. https://doi.org/10.3892/or_00000625